Target intelligence / Profile preview

miR-17-92 microRNA primary transcript (pri-miR-17-92)

Target
pri-miR-17-92
Molecular classification
Other (Primary microRNA transcript, non-coding RNA precursor)
01

Overview

The **pri-miR-17-92** transcript is a long, polycistronic primary microRNA (pri-miRNA) that serves as the precursor for the miR-17-92 cluster, a group of six processed microRNAs (miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92a-1) encoded within the MIR17HG gene[1][2][4]. After being transcribed, the ~800 nucleotide RNA adopts a distinct tertiary structure that determines how individual miRNA precursors within the transcript are processed into mature microRNAs[1][2][3][4]. These mature miRNAs play crucial roles in regulating cell cycle, proliferation, apoptosis, and development. Dysregulation of the miR-17-92 cluster is linked to cancer, cardiovascular disorders, neurodevelopmental disease, and aging, with overexpression particularly associated with oncogenesis[4][5]. Germline deletions of MIR17HG cause syndromic developmental defects in humans and mice[1]. The primary transcript is regulated at both the transcriptional and post-transcriptional level, including modulation by RNA-binding proteins such as hnRNP A1 and splicing factors such as SRSF3[1][6]. Importantly, **pri-miR-17-92 itself is a non-coding precursor molecule and not a direct therapeutic target; rather, the mature microRNAs derived from it, or the processes regulating its biogenesis, are potential intervention points[5].**

Other names
pri-miR-17-92amiR-17~92 primary transcriptMIR17HG primary transcriptmiR-17-92 cluster primary transcript
02

Biological functions

Precursor of mature microRNAs implicated in gene expression regulationRegulates cell cycleInfluences cell proliferationModulates apoptosisInvolved in development
03

Disease associations

CancerNeurodevelopmental disordersCardiovascular diseaseAging-related conditions
04

Safety considerations

Oncogenic potential when dysregulatedGermline deletion causes severe developmental defects
05

Biomarkers

Expression level of miR-17-92 cluster microRNAs (for various cancers and developmental syndromes)

Beyond the preview

Go deeper on miR-17-92 microRNA primary transcript (pri-miR-17-92).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-17-92 microRNA primary transcript (pri-miR-17-92).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call